Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03316924
Other study ID # 6834
Secondary ID
Status Completed
Phase
First received
Last updated
Start date May 29, 2018
Est. completion date May 31, 2023

Study information

Verified date July 2021
Source University Hospital, Strasbourg, France
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

In case of CDH, the incomplete development of a part of the diaphragm allows abdominal viscera to herniate into thorax cavity during fetal development and impaired lung and heart development. After birth, CDH patients who survived thanks to an active reanimation management undergo diaphragmatic repair. In case of large defect, a patch is needed to complete diaphragmatic closure. Thanks to primary cell culture from foreskin, peritoneal epithelium or cremaster dedicated to incineration investigators want to analyse biological integration of actually used prothesis and others innovations.


Recruitment information / eligibility

Status Completed
Enrollment 1
Est. completion date May 31, 2023
Est. primary completion date May 29, 2023
Accepts healthy volunteers No
Gender All
Age group 0 Years to 14 Years
Eligibility Inclusion Criteria: - Minor aged 0 (day of birth) to 14 years - Patient for whom an indication of posthectomy and / or cure of inguinal hernia and / or testicular ectopy is retained - Patient whose legal representatives have agreed to the use of operational waste from mesenchymal tissues (foreskin, cremaster and peritoneum) destined for incineration. - Patient affiliated to a social security scheme Exclusion Criteria: - parents don't agree to the use of its operating waste for research purposes

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Foreskin resection
During the pediatric surgery consultation, the doctor will decide between Foreskin resection, orchidopexie or inguinal hernia repair.

Locations

Country Name City State
France Les Hôpitaux Universitaires de Strasbourg Strasbourg

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Strasbourg, France

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary cell colonization Study cell colonization samples are processed immediately after sampling
Primary quality of the extracellular matrix Quality of the extracellular matrix produced in vitro in contact with the currently used implant materials compared to biomaterials under development samples are processed immediately after sampling